Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine

Gynecologic Oncology
Mark A Kane

Abstract

Development of safe and effective vaccines against human papillomavirus (HPV)-the second vaccine against a major human cancer-is one of the most important medical and public health achievements of this century. As with all new vaccines, HPV is currently expensive and this cost precludes its use in the developing world, which has the greatest burden of disease from HPV-related cancers. Hepatitis B (HB) virus vaccine, which prevents chronic HB infection and related cirrhosis and liver cancer, has been successfully introduced as a routine vaccine for children in 89% of countries, including the poorest. The success of this vaccine provides a model for the introduction of HPV vaccine and control of cervical and other HPV-related cancers and genital warts. Lessons learned from HB vaccine introduction are relevant to our efforts to introduce HPV vaccine globally. As with HB vaccine, introduction of HPV vaccine into national immunization programs and routine use of this vaccine, funded by governments, will be needed to control HPV-related disease on a global basis. Global funding support will be needed to make control a reality for the poorest countries, and the program to accomplish this, the Global Alliance for Vaccines and Immunizat...Continue Reading

References

Mar 2, 1990·JAMA : the Journal of the American Medical Association·M J AlterL A Moyer
Mar 29, 2002·The Journal of Infectious Diseases·Susan T GoldsteinHarold S Margolis
Apr 11, 2003·Current Opinion in Infectious Diseases·Mark A Kane, Alan Brooks
Mar 2, 2005·Annals of Internal Medicine·Brian J McMahonHarold S Margolis
Dec 20, 2005·Vaccine·C John ClementsSteven Wiersma
Sep 5, 2006·Vaccine·Mark A KaneFelicity Cutts
Sep 28, 2006·Tropical Medicine & International Health : TM & IH·Voranush ChongsrisawatYong Poovorawan
Mar 21, 2007·Emerging Infectious Diseases·Elamin H ElbashaRalph P Insinga
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
Jul 12, 2008·Vaccine·Loretta BrabinPierre Van Damme
Jul 22, 2008·BMJ : British Medical Journal·Mark JitW John Edmunds
Sep 18, 2009·Journal of the National Cancer Institute·Mei-Hwei ChangUNKNOWN Taiwan Hepatoma Study Group

❮ Previous
Next ❯

Citations

Aug 29, 2012·Journal of Oncology·Valerie ChewJean-Pierre Abastado
Jul 2, 2011·International Journal for Equity in Health·Janice E Graham, Amrita Mishra
Sep 18, 2013·Revista da Associação Médica Brasileira·Allex Jardim da FonsecaGiacomo Balbinotto Neto
Sep 18, 2015·Cancer Medicine·Vidya VedhamSomdat Mahabir
Jun 21, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Yin Ling Woo, Siti Z Omar
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Allex Jardim Fonseca, Luiz Carlos de Lima Ferreira
Jun 10, 2011·Vaccine·Anton P J MiddelbergMichael R Batzloff
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard H BaileyCharles D Blanke
Feb 20, 2019·Human Vaccines & Immunotherapeutics·Paige W LakeSusan T Vadaparampil
Jan 11, 2018·Annals of Medicine·Aria C AttiaAna E Núñez
Nov 30, 2011·Current Opinion in Obstetrics & Gynecology·Sun-Kuie Tay
Mar 18, 2016·Expert Opinion on Drug Safety·Nicola Principi, Susanna Esposito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.